Back
Citius Pharmaceuticals Stock Price Chart
7 Stocks to Buy and Hold Forever
The result is a select group of high-quality blue-chip stocks.
Sell
24
CTXR
Citius Pharmaceuticals
Last Price:
$0.88
Seasonality Move:
-16.69%
7 Day Trial
ALL ACCESS PASS
$
7
Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing selling pressure, which indicates risk of future bearish movement.
Citius Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.98 | Sell |
| 20-day SMA: | 0.84 | Buy |
| 50-day SMA: | 0.86 | Buy |
| 200-day SMA: | 4.71 | Sell |
| 8-day EMA: | 0.94 | Sell |
| 20-day EMA: | 0.89 | Sell |
| 50-day EMA: | 1.03 | Sell |
| 200-day EMA: | 5.01 | Sell |
Citius Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 49.47 | Sell |
| Chaikin Money Flow: | -244902 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.68 - 0.98) | Buy |
| Bollinger Bands (100): | (0.71 - 2.19) | Sell |
Citius Pharmaceuticals Technical Analysis
| Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Citius Pharmaceuticals Stock
Is Citius Pharmaceuticals Stock a Buy?
-
Citius Pharmaceuticals share price is 0.87 while CTXR 8-day simple moving average is 0.98, which is a Sell signal.
-
The stock price of CTXR is 0.87 while Citius Pharmaceuticals 20-day SMA is 0.84, which makes it a Buy.
-
Citius Pharmaceuticals 50-day simple moving average is 0.86 while CTXR share price is 0.87, making it a Buy technically.
-
CTXR stock price is 0.87 and Citius Pharmaceuticals 200-day simple moving average is 4.71, creating a Sell signal.
CTXR Technical Analysis vs Fundamental Analysis
Sell
24
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy or a Sell?
-
Citius Pharmaceuticals stock is rated a SellThe current Citius Pharmaceuticals [CTXR] share price is $0.87. The Score for CTXR is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Citius Pharmaceuticals Stock Info
Market Cap:
9M
Price in USD:
0.87
Share Volume:
641.8K
Citius Pharmaceuticals 52-Week Range
52-Week High:
26.25
52-Week Low:
0.65
Sell
24
Citius Pharmaceuticals (CTXR)
is a Sell
Citius Pharmaceuticals Share Price Forecast
-
What is the Citius Pharmaceuticals stock price today?The Citius Pharmaceuticals stock price is 0.87 USD today.
-
Will CTXR stock go up or go down?Citius Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Citius Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Pharmaceuticals is overvalued.
Is Citius Pharmaceuticals Stock a Buy?
-
Citius Pharmaceuticals share price is 0.87 while CTXR 8-day exponential moving average is 0.94, which is a Sell signal.
-
The stock price of CTXR is 0.87 while Citius Pharmaceuticals 20-day EMA is 0.89, which makes it a Sell.
-
Citius Pharmaceuticals 50-day exponential moving average is 1.03 while CTXR share price is 0.87, making it a Sell technically.
-
CTXR stock price is 0.87 and Citius Pharmaceuticals 200-day simple moving average is 5.01, creating a Sell signal.
Fundamental Analysis of Citius Pharmaceuticals
Is Citius Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $1.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.93 per share, and an increase next year of $0.63 per share.
Technical Analysis of Citius Pharmaceuticals
Should I short Citius Pharmaceuticals stock?
-
CTXR Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting Citius Pharmaceuticals is a Buy
-
Citius Pharmaceuticals Relative Strength Index (RSI) is 49.47, which suggest Citius Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Citius Pharmaceuticals is (0.68 - 0.98), which suggest Citius Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Citius Pharmaceuticals is (0.71 - 2.19), which suggest Citius Pharmaceuticals is a Sell
* Citius Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.